BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2102659)

  • 1. The effect of adherent peritoneal exudate cells (APECs) and their products on the RPC-5 plasmacytoma growth in vitro.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):267-74. PubMed ID: 2102659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of adherent peritoneal exudate cells on plasmacytoma growth in BALB/c mice.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):287-90. PubMed ID: 2102661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of peritoneal cells on tumors cells growth in vitro.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):37-41. PubMed ID: 8744682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
    McDonald AH; Degrassi A
    Cell Immunol; 1993 Jan; 146(1):157-70. PubMed ID: 8425224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anti-tumour properties of peritoneal exudate cells of conventional germ-free and stimulated mice.
    Fray A; Lorinet AM; Halpern B
    Dev Biol Stand; 1977 Apr 13-15; 38():241-4. PubMed ID: 608509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The requirement of an adherent cell substratum for the growth of developing plasmacytoma cells in vivo.
    Cancro M; Potter M
    J Exp Med; 1976 Dec; 144(6):1554-67. PubMed ID: 1003103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor efficacy of activated macrophages against murine glioma cells].
    Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of tumor necrosis factor alpha by resident peritoneal cells of mice.
    Błach-Olszewska Z; Juszczyk M; Zaczyńska E
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):63-6. PubMed ID: 8239910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.
    Matthews TJ; Weinhold KJ; Langlois AJ; Bolognesi DP
    J Natl Cancer Inst; 1985 Oct; 75(4):703-8. PubMed ID: 3862902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics of binding of Corynebacterium parvum to glass-adherent mouse peritoneal exudate cells.
    Ogmundsdóttir HM; Weir DM
    Clin Exp Immunol; 1976 Nov; 26(2):334-9. PubMed ID: 991461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide and pristane-induced peritoneal exudate requirements for plasma tumor cell colony formation.
    Platica M; Bojko C; Clincea R; Hollander V
    J Natl Cancer Inst; 1982 Feb; 68(2):325-8. PubMed ID: 6950164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation and activation of protein kinase C by the plasma cell tumor-promoting alkane pristane.
    Janz S; Gawrisch K; Lester DS
    Cancer Res; 1995 Feb; 55(3):518-24. PubMed ID: 7834620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth.
    Platica M; Bojko C; Steiner G; Hollander VP
    Cancer Res; 1980 Jul; 40(7):2229-33. PubMed ID: 6248200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
    Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
    Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the enhancement of the antibody response in vitro by C. parvum.
    Slijivíc VS; Brown CA; Watson SR
    Dev Biol Stand; 1977 Apr 13-15; 38():147-52. PubMed ID: 608502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbation of B cell genesis in the bone marrow of pristane-treated mice. Implications for plasmacytoma induction.
    Rico-Vargas SA; Potter M; Osmond DG
    J Immunol; 1995 Mar; 154(5):2082-91. PubMed ID: 7868885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane.
    Avcu F; Ural AU; Yilmaz MI; Ozcan A; Ide T; Kurt B; Yalcin A
    Eur J Haematol; 2005 Jun; 74(6):496-500. PubMed ID: 15876253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.